762
Views
17
CrossRef citations to date
0
Altmetric
Environmental Science

A mechanism for nano-titanium dioxide-induced cytotoxicity in HaCaT cells under UVA irradiation

, &
Pages 1384-1390 | Received 24 Dec 2014, Accepted 06 Feb 2015, Published online: 30 Mar 2015
 

Abstract

Nano-TiO2 has been reported to be an efficient photocatalyst, which is able to produce reactive oxygen species (ROS) under UVA irradiation. In this study, we investigated the effects of nano-TiO2 on the cytotoxicity, induction of apoptosis, and the putative pathways of its actions in HaCaT cells. We show that nano-TiO2 is a potent inducer of apoptosis and that it transduces the apoptotic signal via ROS generation, thereby inducing mitochondrial permeability transition (MPT) and activating Caspase-3 from HaCaT cells. ROS production, mitochondrial alteration, and subsequent apoptotic cell death in nano-TiO2-treated cells were blocked by the MPT pore-blocker cyclosporin A. Taken together, our data indicate that nano-TiO2 induces the ROS-mediated MPT and resultant Caspase-3 activation.

Graphical abstract

Nano-TiO2 led to a significant decrease of cell viability mediated mitochondrial permeability transition (MPT) pore.

Disclosure statement

No potential conflict of interest was reported by the authors.

Additional information

Funding

This work was supported by Natural Science Foundation of Hubei Province [No. 2011CDB372], Wuhan Planning Project of Science and Technology [No. 2014070404010203], Engineering training young people in Wuhan City medical backbone personnel (2014).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.